RIGL - Rigel Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RIGL is currently covered by 4 analysts with an average price target of $64.8. This is a potential upside of $20.28 (45.55%) from yesterday's end of day stock price of $44.52.

Rigel Pharmaceuticals's activity chart (see below) currently has 116 price targets and 119 ratings on display. The stock rating distribution of RIGL is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.93% with an average time for these price targets to be met of 730.53 days.

Highest price target for RIGL is $86, Lowest price target is $47, average price target is $64.8.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD. First documented stock forecast 22-Apr-2016.

Best performing analysts who are covering RIGL - Rigel Pharmaceuticals:

Gary Nachman Do Kim Eun Yang Allison Bratzel Kalpit Patel Kristen Kluska

Currently out of the existing stock ratings of RIGL, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Aug-2018

$86

$46.35 (116.90%)

$69

Buy Since 06-Nov-2017

$85

$45.35 (114.38%)

$85

24 days ago
(19-Oct-2026)

0/27 (0%)

$38.28 (81.93%)

Hold Since 03-Apr-2023

$49

$9.35 (23.58%)

$23

2 months 26 days ago
(17-Aug-2026)

3/3 (100%)

$6.55 (15.43%)

202

Hold Since 07-May-2025

$42

$2.35 (5.93%)

$23

1 years 7 days ago
(05-Nov-2025)

4/11 (36.36%)

$4.15 (10.96%)

1547

Show more analysts

Please expand the browser size to see the chart

What is RIGL (Rigel Pharmaceuticals) average time for price targets to be met?

On average it took 731 days for the stock forecasts to be reached, with an average price target met ratio of 44.93%.

Which analyst most recently updated their price target on RIGL (Rigel Pharmaceuticals)?

Kristen Kluska

Which analyst has the most public recommendations on RIGL (Rigel Pharmaceuticals)?

Kristen Kluska works at CANTOR FITZGERALD and has 13 price targets and 13 ratings on RIGL

Which analyst is the currently most bullish on RIGL (Rigel Pharmaceuticals)?

Joshua Schimmer with the highest potential upside of $70.35

Which analyst is the currently most reserved on RIGL (Rigel Pharmaceuticals)?

Do Kim with the lowest potential downside of -$19.65
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?